Vol.52 No.9 September 2004

Study of clinical significance of PK/PD (pharmacokinetic/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection

Naoko Tanikaze, Masaru Komatsu, Kouichi Shimakawa and Ikuyoshi Yamamoto

Jpn. J. Chemother. 52 (9): 469-473, 2004

Current status of prophylactic antibiotic therapy for prevention of postoperative infections after gastrointestinal surgery A questionnaire covering 3,823 surgeons

Yoshinobu Sumiyamaand Yoshio Takesue

Jpn. J. Chemother. 52 (9): 474-485, 2004

Effects of the Chinese traditional medicines Kakkon-to, Hochu-ekki-to, and Juzen-taiho-to on the antimicrobial activity of clarithromycin in combination with rifampicin against Mycobacterium avium complex within THP-1 human macrophages and A-549 human type II alveolar epithelial cells

Katsumasa Sato, Toshiaki Shimizu, Chiaki Sano and Haruaki Tomioka

Jpn. J. Chemother. 52 (9): 486-489, 2004

Postmarketing study of cefcapene pivoxil tablet

Yoko Ishikawa, Harumichi Maki, Akira Ohtaki, Satoshi Iwakura and Jingoro Shimada

Jpn. J. Chemother. 52 (9): 490-507, 2004

Postmarketing study of cefcapene pivoxil fine granules for children

Yoko Ishikawa, Harumichi Maki, Akira Ohtaki, Satoshi Iwakura and Jingoro Shimada

Jpn. J. Chemother. 52 (9): 508-520, 2004

Analysis of patients with hypoglycemia and/or hyperglycemia induced by gatifloxacin Risk factors and patient profiles

Toshiyuki Tamayama, Yasushi Tanaka and Atsushi Saito

Jpn. J. Chemother. 52 (9): 521-529, 2004